コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 subunit (U2AF65) undergoes posttranslational lysyl-5-hydroxylation catalyzed by the Fe(II) and 2-oxog
2 Hint3-1 and hHint3-2 were found to hydrolyze lysyl-adenylate generated by human lysyl-tRNA synthetase
3 he hydrolysis of purine phosphoramidates and lysyl-adenylate generated by lysyl-tRNA synthetase (LysR
5 nization into plywood-like stacks depends on lysyl aldehyde-derived cross-links introduced by lysyl o
6 DNA phosphate negative charge is balanced by lysyl amines (3.2%), polyamines (5.8%), and monovalent c
7 d monovalent cations (40%); and (iii) 11% of lysyl amines, 40% of -NH(2) groups of polyamines, and 80
9 he ability of hHint1 and echinT to hydrolyze lysyl-AMP generated by either E. coli or human lysyl-tRN
10 on homodimerization and 2) the hydrolysis of lysyl-AMP generated by LysRS is not dependent on homodim
15 tor XIIIa-catalyzed epsilon-(gamma-glutamyl)-lysyl bonds between glutamine and lysine residues on fib
16 Nase P, we synthesized hexa-guanidinium and -lysyl conjugates of neomycin B and compared their inhibi
17 c 110kDa polypeptide (Co-hArgI x3) and (iii) lysyl conjugation of 5kDa PEG-N-hydroxysuccinimide (NHS)
18 yzes the formation of gamma-glutamyl-epsilon-lysyl cross-links within the fibrin blood clot network.
21 that LOXL2 readily promoted the formation of lysyl-derived cross-links in the 7S dodecamer but not in
22 ontrast, inclusion of the positively charged lysyl-dioleoyl-phosphatidylglycerol exclusively on the c
24 recombinant EF-P preparation containing beta-lysyl-EF-P stimulated N-formyl-methionyl-puromycin synth
28 sults from mutations in the genes coding for lysyl hydroxylase (LH) 2 or peptidyl-prolyl cis-trans is
30 in B with the P-domain of calreticulin, with lysyl hydroxylase 1, and probably other proteins, such a
32 on of the alternatively spliced long form of lysyl hydroxylase 2 (LH2), a collagen telopeptide LH.
33 signaling in macrophages to the induction of lysyl hydroxylase 2 (LH2), an enzyme that directs persis
35 -function studies in tumor cells showed that lysyl hydroxylase 2 (LH2), which hydroxylates telopeptid
36 se associated with inactivating mutations in lysyl hydroxylase 2 (LH2/PLOD2) or FK506 binding protein
37 T3-E1 (MC)-derived clones stably suppressing lysyl hydroxylase 3 (LH3) (short hairpin (Sh) clones) an
40 th its partner proteins, regulate sorting of lysyl hydroxylase 3 (LH3, also known as PLOD3) into newl
41 ing hypoxia-inducible factor 1 [HIF-1]), the lysyl hydroxylase JMJD6, and the RNA hydroxylase TYW5 bu
42 R may also act as an arginine demethylase, a lysyl hydroxylase, or an RNA-binding protein through its
43 m of clinical phenotypes than the absence of lysyl-hydroxylase 1 and additionally includes myopathy,
47 -hydroxylation of alpha1(I)Pro986 but excess lysyl hydroxylation and glycosylation along the collagen
48 post-translationally modified by prolyl and lysyl hydroxylation and subsequently by glycosylation of
50 ory deprotonation of enzyme-bound methylated lysyl intermediates, which along with binding and releas
51 6-[(2E)-1- oxo-3-(3-pyridinyl-2-propenyl)]-l-lysyl-l-2-aminohexanedioyl-(1-amino-1-cyclohexa ne)carbo
55 ere we present biochemical evidence for beta-lysyl-lysine modification in Escherichia coli EF-P and f
58 as follows: S-hydroxylysyl-methionine and S-lysyl-methionine cross-links, which stabilize the alpha3
60 Mass spectrometric analyses confirmed the lysyl modification at lysine 34 in native and recombinan
61 on between Phe-19 of the pore module and the lysyl moiety anchored to the phosphatidylglycerol headgr
62 of LigA with NAD(+) to form a covalent LigA-(lysyl-Nzeta)-AMP intermediate (step 1); transfer of AMP
63 along the reaction pathway-covalent ligase-(lysyl-Nzeta)-AMP*Mn(2+) intermediate; ligase*ATP*(Mn(2+)
64 cted an interaction between fibromodulin and lysyl oxidase (a major collagen cross-linking enzyme) an
68 l oxidase family is made up of five members: lysyl oxidase (LOX) and lysyl oxidase-like 1-4 (LOXL1-LO
69 analysis of the hypoxic secretome identified lysyl oxidase (LOX) as significantly associated with bon
71 pression of the collagen crosslinking enzyme lysyl oxidase (LOX) compared with PyMT(fl/fl) mammary ca
72 of the extracellular matrix modifying enzyme lysyl oxidase (LOX) correlates with metastatic dissemina
74 helial-mesenchymal transition marker levels, lysyl oxidase (LOX) expression, and metastatic capacity.
77 through induction of multiple members of the lysyl oxidase (LOX) family, including LOX, LOX-like 2, a
79 ved human MSCs promote de novo production of lysyl oxidase (LOX) from human breast carcinoma cells, w
80 AD, we identified a missense mutation in the lysyl oxidase (LOX) gene (c.893T > G encoding p.Met298Ar
83 such pathologies, and recently, the protein lysyl oxidase (LOX) has been implicated in proliferation
84 The extracellular, matrix-modifying enzyme lysyl oxidase (LOX) has recently been linked to colorect
87 d mast cell protease expression, and induced lysyl oxidase (LOX) in the aortic wall, improved systemi
88 ession and localization of LOXL1, LOXL2, and lysyl oxidase (LOX) in tissues of PEX syndrome/glaucoma
94 of the extracellular matrix-modifying enzyme lysyl oxidase (LOX) is essential for stimulating endothe
99 We studied the functional contribution of lysyl oxidase (LOX) to collagen stabilization and hepati
101 d is then cleaved to a 30-kDa mature enzyme (lysyl oxidase (LOX)) and an 18-kDa propeptide (lysyl oxi
102 ypothesized that HG-induced up-regulation of lysyl oxidase (LOX), a collagen-cross-linking enzyme, in
103 d whether altered expression and activity of lysyl oxidase (LOX), a cross-linking enzyme, may comprom
105 the dramatic reduction in the expression of lysyl oxidase (LOX), a metastasis-promoting, matrix-remo
107 Previously, fibulin-4 was shown to bind lysyl oxidase (LOX), an elastin/collagen cross-linking e
108 A key regulator of collagen homeostasis is lysyl oxidase (LOX), an enzyme responsible for cross-lin
109 ng inhibited by a known suicide inhibitor of lysyl oxidase (LOX), beta-aminopropionitrile, which we f
110 0b; miR-200b directly inhibits expression of lysyl oxidase (LOX), leading to decreased invasion.
111 A series of studies examined the effects of lysyl oxidase (LOX), the enzyme responsible for the form
112 GFbeta1 stimulation increased collagen I and lysyl oxidase (LOX), the enzyme that cross-links soluble
113 cognized targets of the extracellular enzyme lysyl oxidase (LOX), the level of which is increased in
114 supplies Cu to the secretory enzymes such as lysyl oxidase (LOX), while Atox1 in the nucleus function
117 propeptide region (LOX-PP) derived from pro-lysyl oxidase (Pro-LOX) and not on lysyl oxidase enzyme
120 e extracellular matrix enzymes revealed that lysyl oxidase activity is required for cross-linking of
122 p.Ser348Arg resulted in significantly lower lysyl oxidase activity when compared with the wild-type
123 creases in extracellular matrix rigidity and lysyl oxidase activity, which can be prevented by inhibi
124 l aldehyde-derived cross-links introduced by lysyl oxidase activity, which, in turn, only weakly infl
126 protein (MMP-2) and unchanged expression of lysyl oxidase and a second metalloproteinase, MMP-9, in
128 and VI and the collagen crosslinking enzyme lysyl oxidase and up-regulates in vitro expression of th
129 in-4), collagens (types I, III, and IV), and lysyl oxidase crosslinking enzymes (LOX, LOXL1, LOXL2) w
130 Similarly, d-penicillamine, which inhibits lysyl oxidase enzymatic activity by depleting intracereb
134 hydroxylysine would enhance the activity of lysyl oxidase enzyme to form collagen cross-links, incre
138 We also established that LOXL2 is the main lysyl oxidase family member present in the glomerular ex
140 d more recently periostin and members of the lysyl oxidase family of enzymes have been documented in
141 ysyl oxidase-like 2 (LOXL2), a member of the lysyl oxidase family, as a Snail1 regulator and EMT indu
152 found that the collagen cross-linking enzyme lysyl oxidase is expressed in all vascular cells and tha
153 viously shown that proteolytic activation of lysyl oxidase is much reduced in cultures of FN-null mou
155 Lysyl oxidase-like 1 proved to be the major lysyl oxidase isoform in the normal lamina cribrosa in a
161 -terminal catalytic domains that provide for lysyl oxidase or lysyl oxidase-like enzyme activity; and
165 LOX has complex roles in cancer in which the lysyl oxidase propeptide (LOX-PP) domain of secreted pro
167 cally increases intranuclear localization of lysyl oxidase propeptide, which interferes with NF-kappa
169 lloproteinases, IL-8, PDGFs, caveolin 1, and lysyl oxidase), several of which were associated with po
171 creases in the pro-synthetic elastin enzyme, lysyl oxidase, and increases in the elastin-degrading en
172 alpha-amylase, concanavalin, Pichia pastoris lysyl oxidase, and Klebsiella pneumoniae acetolactate sy
174 as those encoding hypoxia-inducible gene-2, lysyl oxidase, and vascular endothelial growth factor, a
175 ltures with inhibitors of TGFbeta signaling, lysyl oxidase, or integrin beta1-mediated mechanosignali
176 relationship exists between fibromodulin and lysyl oxidase, potentially imparting a specific collagen
177 ollagen domain and also forms a complex with lysyl oxidase, targeting the enzyme toward specific cros
178 er280Arg), was identified in LOX, encoding a lysyl oxidase, that segregated with disease in the famil
179 growth factor (PDGF)-BB, angiopoietin-1, and lysyl oxidase-2 and the cerebrovascular-selective protei
182 as reported that mice with null mutations in lysyl oxidase-like 1 (LOXL1) develop pelvic organ prolap
183 Two single nucleotide polymorphisms in the lysyl oxidase-like 1 (LOXL1) gene (rs1048661 and rs38259
185 ation between common genetic variants in the lysyl oxidase-like 1 (LOXL1) gene with pseudoexfoliation
186 Strong genetic risk is conferred by the lysyl oxidase-like 1 (LOXL1) gene, but additional comodu
188 trong familial association and recently, the lysyl oxidase-like 1 gene has been strongly associated w
189 However, the exact relationship between lysyl oxidase-like 1 polymorphisms and the development o
190 is an important risk factor for glaucoma and lysyl oxidase-like 1 polymorphisms are strongly associat
195 essed the steady-state enzymatic activity of lysyl oxidase-like 2 (LOXL2) against the substrates 1,5-
196 derived 3D matrix system and identified anti-lysyl oxidase-like 2 (LOXL2) antibodies that alter the n
200 oxyphenolics required the presence of active lysyl oxidase-like 2 (LOXL2), thereby limiting effects t
201 show that an enzyme that crosslinks collagen-Lysyl oxidase-like 2 (Loxl2)-is essential for interstiti
202 oss-linking domains in elastin and decreased lysyl oxidase-like 2 expression leads to decreased amoun
203 The inclusion of exon 23 in elastin mRNA and lysyl oxidase-like 2 mRNA levels was significantly reduc
204 to be due to disruption of regulatory genes (lysyl oxidase-like and clusterin) that are involved in b
205 ic domains that provide for lysyl oxidase or lysyl oxidase-like enzyme activity; and more divergent p
206 te hypermethylated genes, including LOXL1, a lysyl oxidase-like gene, in human bladder cancer cells.
207 rrent study suggests for the first time that lysyl oxidase-like genes can act as tumor suppressor gen
209 sors histone deacetylases 1 and 2 as well as lysyl oxidase-like protein 3 with Snail1 was impaired wh
211 identified a new role for the matrix enzyme lysyl oxidase-like-2 (LOXL2) in the creation and mainten
214 Among all lysyl oxidase family members, lysyl oxidase-like-2 (LOXL2) was identified as the isofo
215 accompanying intermolecular cross-linking by lysyl oxidase-mediated bonds, is vital to the structural
216 electively affects the extent and pattern of lysyl oxidase-mediated collagen cross-linking by sterica
217 ing as a potential contributor, we inhibited lysyl oxidase-mediated collagen cross-linking, which sig
218 trix compliance in vitro and by manipulating lysyl oxidase-mediated collagen crosslinking in vivo.
228 out the cement proteome, as well as multiple lysyl oxidases and peroxidases, establish homology with
230 e deficiency of LOX in mice or inhibition of lysyl oxidases in turkeys and rats causes aortic dissect
231 nt loss of col8a1a function or inhibition of Lysyl oxidases with drugs during embryogenesis was suffi
232 e, a known inhibitor of the copper-dependent lysyl oxidases, causes notochord distortion in the zebra
233 e inhibitor of the enzymatic activity of all lysyl oxidases, is unable to abolish the LOXL2-induced i
237 the synthesis and translocation of membrane lysyl-phosphatidylglycerol (an mprF-dependent function)
238 of teichoic acids, (ii) the incorporation of lysyl-phosphatidylglycerol in the bacterial membrane and
239 nthase (A-PGS) or by Lys-tRNA(Lys)-dependent lysyl-phosphatidylglycerol synthase (L-PGS) enables bact
240 In parallel, the structure of the related lysyl-phosphatidylglycerol-specific L-PGS domain from Ba
242 e the activity of sirtuins toward additional lysyl posttranslational modifications, and show that sir
243 silicotic rats with N-acetyl-Seryl-Aspartyl-Lysyl-Proline (Ac-SDKP) inhibits myofibroblast different
244 i-fibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) using proteomic profile analysis
246 as the tetrapeptide N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP), play a significant role in contr
247 man carcinoma HEp2 cells show that the 15(2)-lysyl regioisomers accumulate the most within cells, and
254 ive towards tri- and dimethylated histone H3 lysyl residues 9 and 36 (H3K9me3/me2 and H3K36me3/me2),
256 nd 2-oxoglutarate-dependent hydroxylation of lysyl residues in arginine-serine-rich domains of RNA sp
257 deaminases that can modify the side chain of lysyl residues in collagen and elastin, thereby leading
258 at catalyze the site-specific methylation of lysyl residues in histone and non-histone proteins.
259 aches desthiobiotin to one or more conserved lysyl residues in the ATP-binding sites of protein kinas
260 diminished hydroxylation of the telopeptide lysyl residues involved in intermolecular cross-link for
261 f lipid peroxidation that rapidly react with lysyl residues of proteins to form stable protein adduct
262 ifferential methylation of histone H3 and H4 lysyl residues regulates processes including heterochrom
263 structural data suggest how JMJD6 binds its lysyl residues such that it can catalyse C-5 hydroxylati
265 o groups alpha and epsilon (the latter being lysyl residues) on the intact proteins by acetylation.
266 st-translational hydroxylation of prolyl and lysyl residues, as catalyzed by 2-oxoglutarate (2OG)-dep
267 via hydroxylation) of N()-methylated histone lysyl residues, as well as hydroxylation of multiple oth
269 , the aminolysis reactivity of each modified lysyl side chain revealed a preference for reacting with
272 RNA, we discovered that the Escherichia coli lysyl tRNA synthetase was responsible for misacylating t
274 stem eliminated misacylation by the E. coli lysyl tRNA synthetase, and led to the development of a f
276 hydrolyze lysyl-adenylate generated by human lysyl-tRNA synthetase (hLysRS) by proceeding through an
278 is, p.Tyr173SerfsX7, and p.Ile302Met) in the lysyl-tRNA synthetase (KARS) gene in two patients from t
280 e identified at highly conserved residues of lysyl-tRNA synthetase (KARS): the c.1129G>A (p.Asp377Asn
282 nscription primer via an interaction between lysyl-tRNA synthetase (LysRS) and the HIV-1 Gag polyprot
284 Gag and GagPol, as well as host cell factor lysyl-tRNA synthetase (LysRS), are required for specific
286 jeK, encoding truncated homologs of class II lysyl-tRNA synthetase and of lysine-2,3-aminomutase, res
289 d a trans pQTL relationship between the KARS lysyl-tRNA synthetase locus and levels of the DIDO1 prot
292 syl-AMP generated by either E. coli or human lysyl-tRNA synthetase were partially transferable by C-t
293 ural classes, the only known exception being lysyl-tRNA synthetase which exists in both classes I (Ly
294 molar inhibitor of the Plasmodium falciparum lysyl-tRNA synthetase, and exhibits activity against bot
298 ynthetases (LysRS1 and LysRS2) together form lysyl-tRNA(Pyl), a potential intermediate to pyrrolysyl-
299 cells expressing Fet3-Ftr1 lacking cytosolic lysyl ubiquitin acceptor sites, Fet3-Ftr1 is constitutiv
300 expression of SNAT2 in which seven putative lysyl-ubiquitination sites in the cytoplasmic N-terminal
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。